Palisade Bio (PALI) Receivables (2011 - 2023)

Palisade Bio's (PALI) quarterly Receivables came in at $250000.0 in Q1 2023, up 76.99% on a QoQ basis from $141250.0 in Q4 2022.

Palisade Bio (PALI) Receivables (2011 - 2023) Analysis & Trends

Palisade Bio (PALI) has 13 years of Receivables data on file, last reported at $250000.0 in Q1 2023.

  • On a quarterly basis, Receivables changed N/A year-over-year to $250000.0 in Q1 2023; TTM through Mar 2023 was $250000.0, a N/A change from a year earlier, with the FY2022 full-year figure at $141250.0, changed N/A from the prior year.
  • Receivables for Q1 2023 stood at $250000.0, up from $141250.0 in the prior quarter.
  • Over the last five years, Receivables for PALI reached as high as $466782.0 in Q1 2019 and fell as low as $21064.0 in Q4 2019.
  • Historically, Receivables has averaged $222678.8 across 5 years, with a median of $246976.0 in 2020.
  • Across the five-year window, Receivables tumbled 94.12% in 2019 and jumped 1267.26% in 2020, its largest moves.
  • Year by year, Receivables stood at $21064.0 in 2019, then soared by 1267.26% to $288000.0 in 2020, then sank by 79.51% to $59000.0 in 2021, then jumped by 139.41% to $141250.0 in 2022, then surged by 76.99% to $250000.0 in 2023.
  • Per Business Quant data, the three most recent Receivables figures were $250000.0 in Q1 2023, $141250.0 in Q4 2022, and $59000.0 in Q2 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 4.97 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 938.02 Mn
4 NuCana 279.75 Bn 279.75 Bn - 1.13 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 2.00 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 5.73 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.93 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Palisade Bio 985.76 -132.63 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2023 250,000.00
Dec 31, 2022 141,250.00
Jun 30, 2021 59,000.00
Mar 31, 2021 25,259.00
Dec 31, 2020 288,000.00
Sep 30, 2020 237,779.00
Jun 30, 2020 245,938.00
Mar 31, 2020 248,014.00
Dec 31, 2019 21,064.00
Sep 30, 2019 290,154.00
Jun 30, 2019 398,905.00
Mar 31, 2019 466,782.00
Dec 31, 2018 357,995.00
Sep 30, 2018 224,227.00
Jun 30, 2018 478,722.00
Mar 31, 2018 137,372.00
Dec 31, 2017 371,586.00
Sep 30, 2017 595,458.00
Jun 30, 2017 563,345.00
Mar 31, 2017 572,715.00